Ihsan Turan1, B Ian Hutchins2, Bulent Hacihamdioglu3, L Damla Kotan1, Fatih Gurbuz1, Ayca Ulubay4, Eda Mengen1, Bilgin Yuksel1, Susan Wray2, A Kemal Topaloglu1,5. 1. Division of Pediatric Endocrinology, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey. 2. Cellular and Developmental Neurobiology Section, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892. 3. Department of Pediatrics, Gulhane Military Medical Academy Haydarpasa Training Hospital, 34668 Istanbul, Turkey. 4. Department of Forensic Medicine, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey. 5. Department of Neurobiology and Anatomical Sciences, Division of Pediatric Endocrinology, Batson Children's Hospital, University of Mississippi Medical Center, Jackson, Mississippi 39216.
Abstract
Context: Gonadotropin-releasing hormone neurons originate outside the central nervous system in the olfactory placode and migrate into the central nervous system, becoming integral components of the hypothalamic-pituitary-gonadal axis. Failure of this migration can lead to idiopathic hypogonadotropic hypogonadism (IHH)/Kallmann syndrome (KS). We have previously shown that CCDC141 knockdown leads to impaired migration of GnRH neurons but not of olfactory receptor neurons. Objective: The aim of this study was to further describe the phenotype and prevalence of CCDC141 mutations in IHH/KS. Design: Using autozygosity mapping, candidate gene screening, whole-exome sequencing, and Sanger sequencing, those individuals carrying deleterious CDCD141 variants and their phenotypes were determined in a cohort of 120 IHH/KS families. Patients and Interventions: No interventions were made. Results: Our studies revealed nine affected individuals from four independent families in which IHH/KS is associated with inactivating CCDC141 variants, revealing a prevalence of 3.3%. Affected individuals (with the exception of those from family 1 who concomitantly have FEZF1 mutations) have normal olfactory function and anatomically normal olfactory bulbs. Four affected individuals show evidence of clinical reversibility. In three of the families, there was at least one more potentially deleterious variant in other known puberty genes with evidence of allelic heterogeneity within respective pedigrees. Conclusions: These studies confirm that inactivating CCDC141 variants cause normosmic IHH but not KS. This is consistent with our previous in vitro experiments showing exclusively impaired embryonic migration of GnRH neurons upon CCDC141 knockdown. These studies expand the clinical and genetic spectrum of IHH and also attest to the complexity of phenotype and genotype in IHH.
Context:Gonadotropin-releasing hormone neurons originate outside the central nervous system in the olfactory placode and migrate into the central nervous system, becoming integral components of the hypothalamic-pituitary-gonadal axis. Failure of this migration can lead to idiopathic hypogonadotropic hypogonadism (IHH)/Kallmann syndrome (KS). We have previously shown that CCDC141 knockdown leads to impaired migration of GnRH neurons but not of olfactory receptor neurons. Objective: The aim of this study was to further describe the phenotype and prevalence of CCDC141 mutations in IHH/KS. Design: Using autozygosity mapping, candidate gene screening, whole-exome sequencing, and Sanger sequencing, those individuals carrying deleterious CDCD141 variants and their phenotypes were determined in a cohort of 120 IHH/KS families. Patients and Interventions: No interventions were made. Results: Our studies revealed nine affected individuals from four independent families in which IHH/KS is associated with inactivating CCDC141 variants, revealing a prevalence of 3.3%. Affected individuals (with the exception of those from family 1 who concomitantly have FEZF1 mutations) have normal olfactory function and anatomically normal olfactory bulbs. Four affected individuals show evidence of clinical reversibility. In three of the families, there was at least one more potentially deleterious variant in other known puberty genes with evidence of allelic heterogeneity within respective pedigrees. Conclusions: These studies confirm that inactivating CCDC141 variants cause normosmic IHH but not KS. This is consistent with our previous in vitro experiments showing exclusively impaired embryonic migration of GnRH neurons upon CCDC141 knockdown. These studies expand the clinical and genetic spectrum of IHH and also attest to the complexity of phenotype and genotype in IHH.
Authors: Elena Gianetti; Cintia Tusset; Sekoni D Noel; Margaret G Au; Andrew A Dwyer; Virginia A Hughes; Ana Paula Abreu; Jessica Carroll; Ericka Trarbach; Leticia F G Silveira; Elaine M F Costa; Berenice Bilharinho de Mendonça; Margaret de Castro; Adriana Lofrano; Janet E Hall; Erol Bolu; Metin Ozata; Richard Quinton; John K Amory; Susan E Stewart; Wiebke Arlt; Trevor R Cole; William F Crowley; Ursula B Kaiser; Ana Claudia Latronico; Stephanie B Seminara Journal: J Clin Endocrinol Metab Date: 2010-03-23 Impact factor: 5.958
Authors: B Ian Hutchins; L Damla Kotan; Carol Taylor-Burds; Yusuf Ozkan; Paul J Cheng; Fatih Gurbuz; Jean D R Tiong; Eda Mengen; Bilgin Yuksel; A Kemal Topaloglu; Susan Wray Journal: Endocrinology Date: 2016-03-25 Impact factor: 4.736
Authors: Nelly Pitteloud; Richard Quinton; Simon Pearce; Taneli Raivio; James Acierno; Andrew Dwyer; Lacey Plummer; Virginia Hughes; Stephanie Seminara; Yu-Zhu Cheng; Wei-Ping Li; Gavin Maccoll; Anna V Eliseenkova; Shaun K Olsen; Omar A Ibrahimi; Frances J Hayes; Paul Boepple; Janet E Hall; Pierre Bouloux; Moosa Mohammadi; William Crowley Journal: J Clin Invest Date: 2007-01-18 Impact factor: 14.808
Authors: Jia Zhu; Ruth E-Y Choa; Michael H Guo; Lacey Plummer; Cassandra Buck; Mark R Palmert; Joel N Hirschhorn; Stephanie B Seminara; Yee-Ming Chan Journal: J Clin Endocrinol Metab Date: 2015-01-30 Impact factor: 5.958
Authors: Atteeq U Rehman; Regie Lyn P Santos-Cortez; Meghan C Drummond; Mohsin Shahzad; Kwanghyuk Lee; Robert J Morell; Muhammad Ansar; Abid Jan; Xin Wang; Abdul Aziz; Saima Riazuddin; Joshua D Smith; Gao T Wang; Zubair M Ahmed; Khitab Gul; A Eliot Shearer; Richard J H Smith; Jay Shendure; Michael J Bamshad; Deborah A Nickerson; John Hinnant; Shaheen N Khan; Rachel A Fisher; Wasim Ahmad; Karen H Friderici; Sheikh Riazuddin; Thomas B Friedman; Ellen S Wilch; Suzanne M Leal Journal: Eur J Hum Genet Date: 2014-12-10 Impact factor: 4.246
Authors: Tansit Saengkaew; Gerard Ruiz-Babot; Alessia David; Alessandra Mancini; Katia Mariniello; Claudia P Cabrera; Michael R Barnes; Leo Dunkel; Leonardo Guasti; Sasha R Howard Journal: NPJ Genom Med Date: 2021-12-20 Impact factor: 8.617
Authors: Ambroise Wonkam; Samuel Mawuli Adadey; Isabelle Schrauwen; Elvis Twumasi Aboagye; Edmond Wonkam-Tingang; Kevin Esoh; Kalinka Popel; Noluthando Manyisa; Mario Jonas; Carmen deKock; Victoria Nembaware; Diana M Cornejo Sanchez; Thashi Bharadwaj; Abdul Nasir; Jenna L Everard; Magda K Kadlubowska; Liz M Nouel-Saied; Anushree Acharya; Osbourne Quaye; Geoffrey K Amedofu; Gordon A Awandare; Suzanne M Leal Journal: Commun Biol Date: 2022-04-19
Authors: Angela Delaney; Adam B Burkholder; Christopher A Lavender; Lacey Plummer; Veronica Mericq; Paulina M Merino; Richard Quinton; Katie L Lewis; Brooke N Meader; Alessandro Albano; Natalie D Shaw; Corrine K Welt; Kathryn A Martin; Stephanie B Seminara; Leslie G Biesecker; Joan E Bailey-Wilson; Janet E Hall Journal: J Clin Endocrinol Metab Date: 2021-03-08 Impact factor: 6.134